(Q34801099)

4 August 2017

1 reference

title

Obtaining evidence for use by healthcare payers on the success of chronic obstructive pulmonary disease management (English)

1 reference

chronic obstructive pulmonary disease

4 August 2017

main subject

1 reference

Mapel D

1

1 reference

4 August 2017

Pearson M

series ordinal

2

1 reference

4 August 2017

publication date

1 August 2002

1 reference

4 August 2017

1 reference

4 August 2017

volume

96 Suppl C

1 reference

4 August 2017

page(s)

S23-30

1 reference

The burden of chronic obstructive pulmonary disease

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2802%2980031-2

7 January 2021

Measuring the success of treatment for chronic obstructive pulmonary disease--patient, physician and healthcare payer perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2802%2980031-2

7 January 2021

Guidelines for the management of chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2802%2980031-2

7 January 2021

Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2802%2980031-2

7 January 2021

The natural history of chronic airflow obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2802%2980031-2

7 January 2021

Mortality in relation to smoking: 40 years' observations on male British doctors

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2802%2980031-2

7 January 2021

Principles of epidemiological research on adverse and beneficial drug effects.

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2802%2980031-2

7 January 2021

Reliability and validity of the Intercollegiate Stroke Audit Package

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2802%2980031-2

7 January 2021

Audit of acute admissions of COPD: standards of care and management in the hospital setting

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2802%2980031-2

7 January 2021

The health impact of undiagnosed airflow obstruction in a national sample of United States adults

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2802%2980031-2

7 January 2021

A comparison of two methods for estimating the health care costs of epilepsy

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2802%2980031-2

7 January 2021

Health care utilization in chronic obstructive pulmonary disease. A case-control study in a health maintenance organization

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2802%2980031-2

7 January 2021

Utilization in COPD: patient characteristics and diagnostic evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2802%2980031-2

7 January 2021

Inhaled corticosteroids and the risk of mortality and readmission in elderly patients with chronic obstructive pulmonary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2802%2980031-2

7 January 2021

Survival in COPD patients after regular use of fluticasone propionate and salmeterol in general practice

1 reference

https://api.crossref.org/works/10.1016%2FS0954-6111%2802%2980031-2

7 January 2021

10.1016/S0954-6111(02)80031-2

Identifiers

DOI

1 reference

4 August 2017

1 reference